Stocks Falter as Retail Sales, Manufacturing Data Weigh

Upbeat jobless claims failed to inject optimism into the market

Digital Content Manager
Sep 15, 2022 at 11:54 AM
facebook twitter linkedin

Stocks are slipping into red territory this afternoon, as Wall Street weighs the latest economic data. A narrower-than-expected drop in import prices is casting a shadow on strong jobless claims data, while retail sales would have missed the mark were it not for automotive sales. Plus, manufacturing activity data hinted at an economic slowdown as well. At last check, the Dow Jones Industrial Average (DJI) is trading slightly below breakeven, while the S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are firmly lower.

Continue reading for more on today's market, including:

MMC Stats 0915

Star Bulk Carriers (NASDAQ:SBLK) is seeing increased options activity today, with 20,000 calls and 26,000 puts exchanged so far, volume that's nine times the average intraday amount. Most popular is the January 20, 2023 18-strike put, followed closely by the 22-strike call in the same series, with new positions being opened at both. Last seen down 2.6% at $20.36, a driver for today's price action is still unclear. The equity just staged a rally off its Sept. 7 annual low of $18.65, but failed to conquer the $21.50 region, which coincides with overhead pressure at the 20-day moving average.

SBLK 20 Day

One of the best performers on the New York Stock Exchange (NYSE) today is Store Capital Corp(NYSE:STOR). The equity is up 20.1% to trade at $32.17 at last check, after the real estate investment trust (REIT) announced Singapore's GIC and private equity firm Oak Street will acquire it in an all-cash deal valued at roughly $14 million, with the offer price of $32.25 representing a 20.4% premium to the stock's last close. The shares earlier hit their highest level since January, but are down 6.4% year-to-date.

Meanwhile, Shuttle Pharmaceuticals Inc (NASDAQ:SHPH) is towards the bottom of the Nasdaq, last seen down 44.4% at $20.85. Today's massive drop came despite the company receiving new histone deacetylase (HDAC) inhibitor patents in the U.S. and Hong Kong for cancer treatment. The Wall Street newbie has cooled off substantially from its Sept. 1, record high of $126.26, and is now much closer to its initial public offering (IPO) price of $8.12 per share.


Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

Best stocks for October and worst stocks for October


Special Offers from Schaeffer's Trading Partners